Global Syndromic Multiplex Diagnostic Market - Industry Trends and Forecast to 2029
The global syndromic multiplex diagnostic market is projected to register a CAGR of 8.7% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2020, and the forecast period is 2022 to 2029
Market Segmentation
Global Syndromic Multiplex Diagnostic Market - By Product and Services (Reagents & Consumables, Instruments, Software & Accessories and Services), Infection type (Viral, Bacterial, Parasites and Fungal), Disease (Respiratory Infections, Gastroenteritis, Sexually Transmitted Infections, Sepsis, Meningitis and Others), Panels Type (Respiratory Panel, GI-Enteric Panel, SexuallyTransmitted Disease Panel, Blood-Sepsis Panel, Meningitis panel and Others), End User (Clinical Laboratories, Hospitals, Pharmaceutical & Biotechnology Companies, Research Institutes and Others), Country (U.S., Canada, Mexico, Germany, France ,U.K, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Belgium Rest of Europe, China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippine, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) – Industry Trends and Forecast to 2029
Some of the major factors contributing to the growth of global syndromic multiplex diagnostic market are:
• Increase in prevalence of infectious diseases
• Growing technological advancement
• Increasing awareness towards early diagnosis
• Strategic initiatives
Market Players
The major companies which are dealing in the global syndromic multiplex diagnostic are listed below:
• BioFire Diagnostics (A Subsidiary of bioMérieux SA)
• Seegene Inc.
• Luminex Corporation. A DiaSorin Company
• F. Hoffmann-La Roche Ltd
• BD
• Bio-Rad Laboratories, Inc.
• Cepheid (A Subsidiary of Danaher)
• QIAGEN
• Abbott
• Hologic, Inc.
• Thermo Fisher Scientific Inc.
• Siemens Healthcare GmbH
• Akonni Biosystems, Inc.
• Biocartis
• QuantuMDx Group Ltd.
• Bosch Healthcare Solutions GmbH (A Subsidiary Of Robert Bosch GmbH)
• Applied BioCode, Inc.
• Prominex Inc.
• Nanōmix, Inc
• Curetis (A Subsidiary of OpGen, Inc.)
• MiRXES Pte Ltd.
Company Profiles
• BioFire Diagnostics (A Subsidiary of bioMérieux SA)
• Seegene Inc.
• Luminex Corporation. A DiaSorin Company
• F. Hoffmann-La Roche Ltd
• BD
• Bio-Rad Laboratories, Inc.
• Cepheid (A Subsidiary of Danaher)
• QIAGEN
• Abbott
• Hologic, Inc.
• Thermo Fisher Scientific Inc.
• Siemens Healthcare GmbH
• Akonni Biosystems, Inc.
• Biocartis
• QuantuMDx Group Ltd.
• Bosch Healthcare Solutions GmbH (A Subsidiary Of Robert Bosch GmbH)
• Applied BioCode, Inc.
• Prominex Inc.
• Nanōmix, Inc
• Curetis (A Subsidiary of OpGen, Inc.)
• MiRXES Pte Ltd.
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.
- 1 Introduction
- 1.1 Objectives Of The Study
- 1.2 Market Definition
- 1.3 Overview Of Global Syndromic Multiplex Diagnostic Market
- 1.4 Limitations
- 1.5 Markets Covered
- 2 Market Segmentation
- 2.1 Markets Covered
- 2.2 Geographical Scope
- 2.3 Years Considered For The Study
- 2.4 Currency And Pricing
- 2.5 Dbmr Tripod Data Validation Model
- 2.6 Multivariate Modelling
- 2.7 Product And Services Lifeline Curve
- 2.8 Primary Interviews With Key Opinion Leaders
- 2.9 Dbmr Market Position Grid
- 2.10 Market End User Coverage Grid
- 2.11 Vendor Share Analysis
- 2.12 Secondary Sources
- 2.13 Assumptions
- 3 Executive Summary
- 4 Premium Insights
- 4.1 Pestel Analysis
- 4.2 Porter's Five Forces
- 4.3 Market Share Per Panel, For Top 3 Players (2021)
- 5 Global Syndromic Multiplex Diagnostic Market: Regulations
- 6 Market Overview
- 6.1 Drivers
- 6.1.1 Rising Prevalence Of Infectious Diseases
- 6.1.2 Rising Adoption Of Molecular Diagnostics Techniques
- 6.1.3 Increasing Regulatory Approval For Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-cov-2) Testing
- 6.1.4 Increasing Demand For Fast And Accurate Diagnostic Results
- 6.2 Restraints
- 6.2.1 High Cost Of Diagnostic Products
- 6.2.2 Explicit Limitation Of Syndromic Multiplex Diagnostic
- 6.3 Opportunities
- 6.3.1 Strategic Initiatives Taken By Market Players
- 6.3.2 Rising Diagnostic Healthcare Expenditure
- 6.3.3 Introduction Of Technological Advanced Products
- 6.4 Challenges
- 6.4.1 Product Recalls
- 6.4.2 Lack Of Skilled Professionals And Barriers Faced In Conducting Diagnostic Tests
- 7 Global Syndromic Multiplex Diagnostic Market, By Product & Services
- 7.1 Overview
- 7.2 Reagents & Consumables
- 7.3 Instruments, Software & Accessories
- 7.4 Services
- 8 Global Syndromic Multiplex Diagnostic Market, By Infection Type
- 8.1 Overview
- 8.2 Viral
- 8.2.1 Coronavirus
- 8.2.2 Influenza Virus
- 8.2.3 Adenovirus
- 8.2.4 Rhinovirus
- 8.2.5 Rotavirus
- 8.2.6 Others
- 8.3 Bacterial
- 8.3.1 Pneumoniae
- 8.3.2 Bordetella Pertussis
- 8.3.3 Staphylococcus
- 8.3.4 Others
- 8.4 Parasites
- 8.5 Fungal
- 9 Global Syndromic Multiplex Diagnostic Market, By Disease
- 9.1 Overview
- 9.2 Respiratory Infections
- 9.3 Gastroenteritis
- 9.4 Sexually Transmitted Infections
- 9.5 Sepsis
- 9.6 Meningitis
- 9.7 Others
- 10 Global Syndromic Multiplex Diagnostic Market, By Panels Type
- 10.1 Overview
- 10.2 Respiratory Panel
- 10.3 Gi-enteric Panel
- 10.4 Sexually Transmitted Disease Panel
- 10.5 Blood-sepsis Panel
- 10.6 Meningitis Panel
- 10.7 Others
- 11 Global Syndromic Multiplex Diagnostic Market, By End User
- 11.1 Overview
- 11.2 Hospitals
- 11.3 Clinical Laboratories
- 11.4 Pharmaceutical & Biotechnology Companies
- 11.5 Research Institutes
- 11.6 Others
- 12 Global Syndromic Multiplex Diagnostic Market, By Region
- 12.1 Overview
- 12.2 North America
- 12.2.1 U.S.
- 12.2.2 Canada
- 12.2.3 Mexico
- 12.3 Europe
- 12.3.1 Germany
- 12.3.2 U.K.
- 12.3.3 France
- 12.3.4 Italy
- 12.3.5 Spain
- 12.3.6 Netherlands
- 12.3.7 Switzerland
- 12.3.8 Russia
- 12.3.9 Belgium
- 12.3.10 Turkey
- 12.3.11 Rest Of Europe
- 12.4 Asia-pacific
- 12.4.1 China
- 12.4.2 Japan
- 12.4.3 India
- 12.4.4 South Korea
- 12.4.5 Australia
- 12.4.6 Singapore
- 12.4.7 Thailand
- 12.4.8 Malaysia
- 12.4.9 Indonesia
- 12.4.10 Philippines
- 12.4.11 Rest Of Asia-pacific
- 12.5 South America
- 12.5.1 Brazil
- 12.5.2 Argentina
- 12.5.3 Rest Of South America
- 12.6 Middle East And Africa
- 12.6.1 South Africa
- 12.6.2 Saudi Arabia
- 12.6.3 U.A.E
- 12.6.4 Israel
- 12.6.5 Egypt
- 12.6.6 Rest Of Middle East And Africa
- 13 Global Syndromic Multiplex Diagnostic Market: Company Landscape
- 13.1 Company Share Analysis: Global
- 13.2 Company Share Analysis: North America
- 13.3 Company Share Analysis: Europe
- 13.4 Company Share Analysis: Asia-pacific
- 14 Swot Analysis
- 15 Company Profile
- 15.1 Biofire Diagnostics (A Subsidiary Of Biomérieux Sa)
- 15.1.1 Company Snapshot
- 15.1.2 Revenue Analysis
- 15.1.3 Company Share Analysis
- 15.1.4 Product Portfolio
- 15.1.5 Recent Developments
- 15.2 F. Hoffmann-la Roche Ltd
- 15.2.1 Company Snapshot
- 15.2.2 Revenue Analysis
- 15.2.3 Company Share Analysis
- 15.2.4 Product Portfolio
- 15.2.5 Recent Development
- 15.3 Luminex Corporation. A Diasorin Company
- 15.3.1 Company Snapshot
- 15.3.2 Recent Financials
- 15.3.3 Company Share Analysis
- 15.3.4 Product Portfolio
- 15.3.5 Recent Development
- 15.4 Cepheid (A Subsidiary Of Danaher)
- 15.4.1 Company Snapshot
- 15.4.2 Recent Financials
- 15.4.3 Company Share Analysis
- 15.4.4 Product Portfolio
- 15.4.5 Recent Developments
- 15.5 Qiagen
- 15.5.1 Company Snapshot
- 15.5.2 Recent Financials
- 15.5.3 Company Share Analysis
- 15.5.4 Product Portfolio
- 15.5.5 Recent Development
- 15.6 Abbott
- 15.6.1 Company Snapshot
- 15.6.2 Revenue Analysis
- 15.6.3 Product Portfolio
- 15.6.4 Recent Development
- 15.7 Akonni Biosystems, Inc.
- 15.7.1 Company Snapshot
- 15.7.2 Product Portfolio
- 15.7.3 Recent Development
- 15.8 Applied Biocode, Inc.
- 15.8.1 Company Snapshot
- 15.8.2 Product Portfolio
- 15.8.3 Recent Developments
- 15.9 Bd
- 15.9.1 Company Snapshot
- 15.9.2 Revenue Analysis
- 15.9.3 Product Portfolio
- 15.9.4 Recent Developments
- 15.10 Biocartis
- 15.10.1 Company Snapshot
- 15.10.2 Revenue Analysis
- 15.10.3 Product Portfolio
- 15.10.4 Recent Development
- 15.11 Bio-rad Laboratories, Inc.
- 15.11.1 Company Snapshot
- 15.11.2 Revenue Analysis
- 15.11.3 Product Portfolio
- 15.11.4 Recent Development
- 15.12 Bosch Healthcare Solutions Gmbh (A Subsidiary Of Robert Bosch Gmbh)
- 15.12.1 Company Snapshot
- 15.12.2 Revenue Analysis
- 15.12.3 Product Portfolio
- 15.12.4 Recent Development
- 15.13 Curetis (A Subsidiary Of Opgen, Inc.)
- 15.13.1 Company Snapshot
- 15.13.2 Recent Financials
- 15.13.3 Product Portfolio
- 15.13.4 Recent Developments
- 15.14 Hologic, Inc.
- 15.14.1 Company Snapshot
- 15.14.2 Recent Financials
- 15.14.3 Product Portfolio
- 15.14.4 Recent Development
- 15.15 Mirxes Pte Ltd.
- 15.15.1 Company Snapshot
- 15.15.2 Product Portfolio
- 15.15.3 Recent Development
- 15.16 Nanōmix, Inc.
- 15.16.1 Company Snapshot
- 15.16.2 Product Portfolio
- 15.16.3 Recent Development
- 15.17 Prominex Inc.
- 15.17.1 Company Snapshot
- 15.17.2 Product Portfolio
- 15.17.3 Recent Development
- 15.18 Quantumdx Group Ltd.
- 15.18.1 Company Snapshot
- 15.18.2 Product Portfolio
- 15.18.3 Recent Developments
- 15.19 Seegene Inc.
- 15.19.1 Company Snapshot
- 15.19.2 Revenue Analysis
- 15.19.3 Product Portfolio
- 15.19.4 Recent Developments
- 15.20 Siemens Healthcare Gmbh
- 15.20.1 Company Snapshot
- 15.20.2 Recent Financials
- 15.20.3 Product Portfolio
- 15.20.4 Recent Development
- 15.21 Thermofisher Scientific Inc.
- 15.21.1 Company Snapshot
- 15.21.2 Recent Financials
- 15.21.3 Product Portfolio
- 15.21.4 Recent Development
- 16 Questionnaire
- 17 Related Reports
- List Of Figures
- Figure 1 Global Syndromic Multiplex Diagnostic Market: Segmentation
- Figure 2 Global Syndromic Multiplex Diagnostic Market: Data Triangulation
- Figure 3 Global Syndromic Multiplex Diagnostic Market: Droc Analysis
- Figure 4 Global Syndromic Multiplex Diagnostic Market: Global Vs Regional Market Analysis
- Figure 5 Global Syndromic Multiplex Diagnostic Market: Company Research Analysis
- Figure 6 Global Syndromic Multiplex Diagnostic Market: Interview Demographics
- Figure 7 Global Syndromic Multiplex Diagnostic Market: Dbmr Market Position Grid
- Figure 8 Global Syndromic Multiplex Diagnostic Market: End User Coverage Grid
- Figure 9 Global Syndromic Multiplex Diagnostic Market: Vendor Share Analysis
- Figure 10 Global Syndromic Multiplex Diagnostic Market: Segmentation
- Figure 11 Increasing Prevalence And Incidence Of Infectious Diseases Is Expected To Drive The Global Syndromic Multiplex Diagnostic Market In The Forecast Period
- Figure 12 Reagents & Consumables Segment Is Expected To Account For The Largest Share Of The Global Syndromic Multiplex Diagnostic Market In 2022 & 2029
- Figure 13 North America Is Expected To Dominate The Global Syndromic Multiplex Diagnostic Market And Asia-pacific Is Expected To Grow With The Highest Cagr In The Forecast Period
- Figure 14 Asia-pacific Is The Fastest-growing Market For Global Syndromic Multiplex Diagnostic Market Manufacturers In The Forecast Period
- Figure 15 Drivers, Restraints, Opportunities, And Challenges Of Global Syndromic Multiplex Diagnostic Market
- Figure 16 Total Cases Of Covid-19 In North America
- Figure 17 Total Cases Of Covid-19 In Europe
- Figure 18 National Health Expenditure Vs Medical Device Expenditure, U.S., 2019
- Figure 19 Global Syndromic Multiplex Diagnostic Market: By Product & Services, 2021
- Figure 20 Global Syndromic Multiplex Diagnostic Market: By Product & Services, 2022-2029 (Usd Million)
- Figure 21 Global Syndromic Multiplex Diagnostic Market: By Product & Services, Cagr (2022-2029)
- Figure 22 Global Syndromic Multiplex Diagnostic Market: By Product & Services, Lifeline Curve
- Figure 23 Global Syndromic Multiplex Diagnostic Market: By Infection Type, 2021
- Figure 24 Global Syndromic Multiplex Diagnostic Market: By Infection Type, 2022-2029 (Usd Million)
- Figure 25 Global Syndromic Multiplex Diagnostic Market: By Infection Type, Cagr (2022-2029)
- Figure 26 Global Syndromic Multiplex Diagnostic Market: By Infection Type, Lifeline Curve
- Figure 27 Global Syndromic Multiplex Diagnostic Market: By Disease, 2021
- Figure 28 Global Syndromic Multiplex Diagnostic Market: By Disease, 2022-2029 (Usd Million)
- Figure 29 Global Syndromic Multiplex Diagnostic Market: By Disease, Cagr (2022-2029)
- Figure 30 Global Syndromic Multiplex Diagnostic Market: By Disease, Lifeline Curve
- Figure 31 Global Syndromic Multiplex Diagnostic Market: By Panels Type, 2021
- Figure 32 Global Syndromic Multiplex Diagnostic Market: By Panels Type, 2022-2029 (Usd Million)
- Figure 33 Global Syndromic Multiplex Diagnostic Market: By Panels Type, Cagr (2022-2029)
- Figure 34 Global Syndromic Multiplex Diagnostic Market: By Panels Type, Lifeline Curve
- Figure 35 Global Syndromic Multiplex Diagnostic Market: By End User, 2021
- Figure 36 Global Syndromic Multiplex Diagnostic Market: By End User, 2022-2029 (Usd Million)
- Figure 37 Global Syndromic Multiplex Diagnostic Market: By End User, Cagr (2022-2029)
- Figure 38 Global Syndromic Multiplex Diagnostic Market: By End User, Lifeline Curve
- Figure 39 Global Syndromic Multiplex Diagnostic Market: Snapshot (2021)
- Figure 40 Global Syndromic Multiplex Diagnostic Market: By Region (2021 )
- Figure 41 Global Syndromic Multiplex Diagnostic Market: By Region (2022 & 2029)
- Figure 42 Global Syndromic Multiplex Diagnostic Market: By Region (2021 & 2029)
- Figure 43 Global Syndromic Multiplex Diagnostic Market: By Product And Services (2022-2029)
- Figure 44 North America Syndromic Multiplex Diagnostic Market: Snapshot (2021)
- Figure 45 North America Syndromic Multiplex Diagnostic Market: By Country (2021)
- Figure 46 North America Syndromic Multiplex Diagnostic Market: By Country (2022 & 2029)
- Figure 47 North America Syndromic Multiplex Diagnostic Market: By Country (2021 & 2029)
- Figure 48 North America Syndromic Multiplex Diagnostic Market: By Product And Services (2022-2029)
- Figure 49 Europe Syndromic Multiplex Diagnostic Market: Snapshot (2021)
- Figure 50 Europe Syndromic Multiplex Diagnostic Market: By Country (2021)
- Figure 51 Europe Syndromic Multiplex Diagnostic Market: By Country (2022 & 2029)
- Figure 52 Europe Syndromic Multiplex Diagnostic Market: By Country (2021 & 2029)
- Figure 53 Europe Syndromic Multiplex Diagnostic Market: By Product And Services (2022-2029)
- Figure 54 Asia-pacific Syndromic Multiplex Diagnostic Market: Snapshot (2021)
- Figure 55 Asia-pacific Syndromic Multiplex Diagnostic Market: By Country (2021)
- Figure 56 Asia-pacific Syndromic Multiplex Diagnostic Market: By Country (2022 & 2029)
- Figure 57 Asia-pacific Syndromic Multiplex Diagnostic Market: By Country (2021 & 2029)
- Figure 58 Asia-pacific Syndromic Multiplex Diagnostic Market: By Product And Services (2022-2029)
- Figure 59 South America Syndromic Multiplex Diagnostic Market: Snapshot (2021)
- Figure 60 South America Syndromic Multiplex Diagnostic Market: By Country (2021 & 2029)
- Figure 61 South America Syndromic Multiplex Diagnostic Market: By Country (2022 & 2029)
- Figure 62 South America Syndromic Multiplex Diagnostic Market: By Country (2021 & 2029)
- Figure 63 South America Syndromic Multiplex Diagnostic Market: By Product And Services (2022-2029)
- Figure 64 Middle East And Africa Syndromic Multiplex Diagnostic Market: Snapshot (2021)
- Figure 65 Middle East And Africa Syndromic Multiplex Diagnostic Market: By Country (2021)
- Figure 66 Middle East And Africa Syndromic Multiplex Diagnostic Market: By Country (2022 & 2029)
- Figure 67 Middle East And Africa Syndromic Multiplex Diagnostic Market: By Country (2021 & 2029)
- Figure 68 Middle East And Africa Syndromic Multiplex Diagnostic Market: By Product And Services (2022-2029)
- Figure 69 Global Syndromic Multiplex Diagnostic Market: Company Share 2021 (%)
- Figure 70 North America Syndromic Multiplex Diagnostic Market: Company Share 2021 (%)
- Figure 71 Europe Syndromic Multiplex Diagnostic Market: Company Share 2021 (%)
- Figure 72 Asia-pacific Syndromic Multiplex Diagnostic Market: Company Share 2021 (%)
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook